UNSPSC 85523809: Supplement left basilic vein with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left basilic vein with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UC37Z

UNSPSC 85523809 Supplement left basilic vein with autologous tissue substitute, percutaneous approach is a Commodity code, but the code shows no relevant recent state and local procurement activity. The recent opportunities posted under this code — a jail medical services contract, pharmacy benefit management services, virtual primary care services, peer support worker training, and fire department medical direction — are healthcare administration, mental health services, and staffing solicitations unrelated to the specific vascular surgical procedure the code nominates. No state or local jurisdiction has recently solicited vascular tissue supplementation, autologous tissue substitutes, or percutaneous vascular procedures under this UNSPSC designation.

The mismatch between the code's clinical scope and the actual work being tagged suggests either systematic miscoding of healthcare procurement or a taxonomy error in the source data. Firms pursuing state and local healthcare contracts in the jurisdictions shown — Georgia, Florida, and California — should monitor these issuing bodies' procurement channels directly rather than rely on this code for signal. The recent opportunities themselves (Columbus Consolidated Government's inmate medical services RFP due May 15, 2026; Collier County's pharmacy benefit management RFP due April 9, 2026; Monroe County's virtual primary care RFP due April 16, 2026) reflect demand for comprehensive healthcare administration and delivery contracting, not medical devices or surgical supplies.